Literature DB >> 1696566

Increased intra-articular substance P and prostaglandin E2 following injection of interleukin-1 in rabbits.

E M O'Byrne1, V J Blancuzzi, D E Wilson, M Wong, J Peppard, J P Simke, A Y Jeng.   

Abstract

Inflammation was induced by intra-articular injection of 100 ng recombinant human interleukin-1 alpha (rhIL-1) into rabbit knees. Substance P (SP) and prostaglandin E2 (PGE2) were measured by radioimmunoassay (RIA) in the joint fluid at 4, 24 and 48 h after rhIL-1 injection. SP was increased by 4 h, further increased at 24 h and remained elevated at 48 h. PGE2 concentration was highest at 4 h and remained elevated at 48 h after rhIL-1 injection. Because of the proinflammatory activities of SP and PGE2, our studies suggest that the elevated SP and PGE2, in the joint may amplify or sustain an initial receptor-mediated inflammatory response to IL-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696566

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  4 in total

1.  Effects of indomethacin, triamcinolone, and dexamethasone on recombinant human interleukin-1-induced substance P and prostaglandin E2 levels in rabbit knee joints.

Authors:  E M O'Byrne; V Blancuzzi; D Wilson; M Wong; J Peppard; J P Simke; A Y Jeng
Journal:  Agents Actions       Date:  1991-09

2.  Pharmacological modulation of rat monocytes: in vivo effects on Ia expression and interleukin-1 production.

Authors:  E J Schenkelaars; H N Singh; R L Goldberg; J R Doughty; J Peppard; G DiPasquale; F Quagliata
Journal:  Agents Actions       Date:  1991-09

3.  Relationship of blood markers to disease severity and drug efficacy in rat adjuvant arthritis.

Authors:  J R Doughty; R L Goldberg; E J Schenkelaars; H N Singh; J Peppard; W Haston; V J Blancuzzi; G Di Pasquale
Journal:  Agents Actions       Date:  1991-09

4.  Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin.

Authors:  M K Herbert; P Holzer
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.